Medindia

X

CSL Behring Receives FDA Approval to Extend Shelf Life for Privigen(R) from 24 to 36 Months

Monday, April 19, 2010 General News J E 4
Advertisement
Increases convenience, ease of use for primary immunodeficiency patients and health providers

Contact:

Greg Healy, Senior Manager, Communications & Public Relations

U.S. Commercial Operations

CSL Behring

610-878-4841

Greg.Healy@cslbehring.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Founder of Dell Subsidiary, Alienware Corp., Alex ...
S
Access Pharma's CEO Interviewed By Proactive Inves...